Regulatory Services

This unique event brings together leading discovery scientists, developers, CMC experts, regulatory specialists and technology providers to discuss advances in next-generation oligonucleotide and precision therapeutics throughout the drug development process.

The World Vaccine Congress is an award-winning series of conferences and exhibitions that
have grown to become the largest and most established vaccine meetings of their kind across
the globe. Our credibility is shown through the prestigious scientific advisory board that spend
months of hard work creating a new and topical agenda, year on year.

We’re excited to be moving to Amsterdam to leverage the well-established life science
ecosystem. Amsterdam is home to numerous pharmaceutical and biotechnology companies
(Boehringer Ingelheim, MSD, Moderna), research institutions (University of Amsterdam,
Amsterdam UMC), government (EMA, RIVM, ZIN) and healthcare organizations that focus
on innovation in vaccines. The proximity of relevant stakeholders and key players will incite
meaningful networking, collaboration, and discussions.

Now in its 26th annual edition, the World Vaccine Congress Europe will continue to bring experts
from the whole value chain under one roof, where you get to meet decision makers and listen to
KOL’s in the areas that are most applicable for your business offering.

The World Vaccine & Immunotherapy Congress West Coast is part of an award-winning series of conferences and exhibitions that are continuously growing becoming the largest and most established vaccine meetings of its kind across the globe. Scientific Affairs • Immunotherapy • Influenza • Infectious Disease • R&D • Regulatory Affairs • Manufacturing • Immunology • Oncology • Vaccines • Clinical Development • Partnerships

With more than 6,500 toxicologists from all over the world expected to attend, opportunities for networking and finding new collaborators are abundant—from the Scientific Sessions and other daytime events through the evening receptions. Research organizations, government agencies, drug developers, regulatory authorities, academic institutions, laboratory and medical suppliers, or consultants are encouraged to exhibit at ToxExpo.

The RDD conference series impacts regulatory and scientific policies worldwide and is recognized as one of the premier international meetings in this area. Its success is founded on the selection of internationally renowned speakers addressing salient topics in pulmonary and nasal drug delivery, lively audience participation, and the financial support of organizations with a proven commitment to, and record of, innovation in the field of inhalation aerosols.

RAPS Convergence is the largest and most well-recognized annual gathering of regulatory professionals, scientists, and innovators in the world. Convergence brings together representatives from industry, global regulatory bodies, and research, academic and clinical organizations that are directly involved in managing the regulatory process and aligning science, regulation, and business strategy.

PharmaSUG is the premier event of the year for statistical programmers, statisticians, data managers, researchers, and others who analyze data in the life sciences.   The programmers who used to attend this conference are now managers, directors, and executives. These individuals are now also involved in statistics, data management, and regulatory submission preparation. As you will see below, the attendees represent the technical and executive leadership covering pharmaceutical, biotechnology,
and the CRO industry. 

Patients as Partners® specializes in the relationship between pharma clinical operations and patients and patient advocacy in how to drive greater clinical efficiencies and great value for all stakeholders.

Co-produced with industry, patients and public-sector voices, the Patients as Partners events are the only conferences that demonstrate how Pharma can involve patients throughout the entire clinical development life cycle to drive greater efficiencies in clinical research.  The conferences delve into patient engagement ideas, strategies, partnerships, and tools to advance patient participation and achieve better outcomes in trials.

An intensive 2-day in person meeting that delves into the latest in vaccine research, platform technologies, analytics and vaccine development & a meeting place for experts working within cutting-edge vaccine research & development. From new and exciting to the latest in products & services, our event will bring together over 200 leading companies for engaging discussions, knowledge sharing and focused networking.